Global Genomics In Cancer Care Market Insights, Forecast to 2029

Publisher Name :
Date: 14-Aug-2023
No. of pages: 118
Inquire Before Buying

Market Analysis and Insights: Global Genomics In Cancer Care Market

The global Genomics In Cancer Care market is projected to grow from US$ 32040 million in 2023 to US$ 70990 million by 2029, at a Compound Annual Growth Rate (CAGR) of 14.2% during the forecast period.

The US & Canada market for Genomics In Cancer Care is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Genomics In Cancer Care is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Genomics In Cancer Care is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Genomics In Cancer Care include Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Genomics In Cancer Care market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Genomics In Cancer Care, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Genomics In Cancer Care, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genomics In Cancer Care revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Genomics In Cancer Care market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Genomics In Cancer Care revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc.

By Company

- Illumina

- Thermo Fisher scientific

- Agilent

- Roche

- Cancer Genetics

- Beckman Coulter

- Bio-Rad

- Danaher

- Sigma Aldrich

- Pacific Biosciences

- Quest Diagnostics

- Luminex

- Oxford Gene Technology

- PerkinElmer

- Qiagen

- GE Healthcare

Segment by Type

- Instruments

- Consumables

- Services

Segment by Application

- Diagnostics

- Personalized Medicine

- Drug Discovery

- Development

- Research

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Genomics In Cancer Care in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genomics In Cancer Care companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genomics In Cancer Care revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Genomics In Cancer Care Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2018-2029)
2.2 Global Genomics In Cancer Care Growth Trends by Region
2.2.1 Genomics In Cancer Care Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genomics In Cancer Care Historic Market Size by Region (2018-2023)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Region (2024-2029)
2.3 Genomics In Cancer Care Market Dynamics
2.3.1 Genomics In Cancer Care Industry Trends
2.3.2 Genomics In Cancer Care Market Drivers
2.3.3 Genomics In Cancer Care Market Challenges
2.3.4 Genomics In Cancer Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Genomics In Cancer Care by Players
3.1.1 Global Genomics In Cancer Care Revenue by Players (2018-2023)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2018-2023)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Genomics In Cancer Care, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2022
3.5 Global Key Players of Genomics In Cancer Care Head office and Area Served
3.6 Global Key Players of Genomics In Cancer Care, Product and Application
3.7 Global Key Players of Genomics In Cancer Care, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2018-2023)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2024-2029)
5 Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2018-2023)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2018-2029)
6.2 North America Genomics In Cancer Care Market Size by Type
6.2.1 North America Genomics In Cancer Care Market Size by Type (2018-2023)
6.2.2 North America Genomics In Cancer Care Market Size by Type (2024-2029)
6.2.3 North America Genomics In Cancer Care Market Share by Type (2018-2029)
6.3 North America Genomics In Cancer Care Market Size by Application
6.3.1 North America Genomics In Cancer Care Market Size by Application (2018-2023)
6.3.2 North America Genomics In Cancer Care Market Size by Application (2024-2029)
6.3.3 North America Genomics In Cancer Care Market Share by Application (2018-2029)
6.4 North America Genomics In Cancer Care Market Size by Country
6.4.1 North America Genomics In Cancer Care Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Genomics In Cancer Care Market Size by Country (2018-2023)
6.4.3 North America Genomics In Cancer Care Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2018-2029)
7.2 Europe Genomics In Cancer Care Market Size by Type
7.2.1 Europe Genomics In Cancer Care Market Size by Type (2018-2023)
7.2.2 Europe Genomics In Cancer Care Market Size by Type (2024-2029)
7.2.3 Europe Genomics In Cancer Care Market Share by Type (2018-2029)
7.3 Europe Genomics In Cancer Care Market Size by Application
7.3.1 Europe Genomics In Cancer Care Market Size by Application (2018-2023)
7.3.2 Europe Genomics In Cancer Care Market Size by Application (2024-2029)
7.3.3 Europe Genomics In Cancer Care Market Share by Application (2018-2029)
7.4 Europe Genomics In Cancer Care Market Size by Country
7.4.1 Europe Genomics In Cancer Care Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Genomics In Cancer Care Market Size by Country (2018-2023)
7.4.3 Europe Genomics In Cancer Care Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Genomics In Cancer Care Market Size (2018-2029)
8.2 China Genomics In Cancer Care Market Size by Type
8.2.1 China Genomics In Cancer Care Market Size by Type (2018-2023)
8.2.2 China Genomics In Cancer Care Market Size by Type (2024-2029)
8.2.3 China Genomics In Cancer Care Market Share by Type (2018-2029)
8.3 China Genomics In Cancer Care Market Size by Application
8.3.1 China Genomics In Cancer Care Market Size by Application (2018-2023)
8.3.2 China Genomics In Cancer Care Market Size by Application (2024-2029)
8.3.3 China Genomics In Cancer Care Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Genomics In Cancer Care Market Size (2018-2029)
9.2 Asia Genomics In Cancer Care Market Size by Type
9.2.1 Asia Genomics In Cancer Care Market Size by Type (2018-2023)
9.2.2 Asia Genomics In Cancer Care Market Size by Type (2024-2029)
9.2.3 Asia Genomics In Cancer Care Market Share by Type (2018-2029)
9.3 Asia Genomics In Cancer Care Market Size by Application
9.3.1 Asia Genomics In Cancer Care Market Size by Application (2018-2023)
9.3.2 Asia Genomics In Cancer Care Market Size by Application (2024-2029)
9.3.3 Asia Genomics In Cancer Care Market Share by Application (2018-2029)
9.4 Asia Genomics In Cancer Care Market Size by Region
9.4.1 Asia Genomics In Cancer Care Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Genomics In Cancer Care Market Size by Region (2018-2023)
9.4.3 Asia Genomics In Cancer Care Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type
10.2.1 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application
10.3.1 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country
10.4.1 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Introduction
11.1.4 Illumina Revenue in Genomics In Cancer Care Business (2018-2023)
11.1.5 Illumina Recent Developments
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Details
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
11.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2018-2023)
11.2.5 Thermo Fisher scientific Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Introduction
11.3.4 Agilent Revenue in Genomics In Cancer Care Business (2018-2023)
11.3.5 Agilent Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Introduction
11.4.4 Roche Revenue in Genomics In Cancer Care Business (2018-2023)
11.4.5 Roche Recent Developments
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Details
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Introduction
11.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2018-2023)
11.5.5 Cancer Genetics Recent Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Introduction
11.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2018-2023)
11.6.5 Beckman Coulter Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Introduction
11.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2018-2023)
11.7.5 Bio-Rad Recent Developments
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Introduction
11.8.4 Danaher Revenue in Genomics In Cancer Care Business (2018-2023)
11.8.5 Danaher Recent Developments
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
11.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2018-2023)
11.9.5 Sigma Aldrich Recent Developments
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Details
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
11.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2018-2023)
11.10.5 Pacific Biosciences Recent Developments
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Details
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
11.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2018-2023)
11.11.5 Quest Diagnostics Recent Developments
11.12 Luminex
11.12.1 Luminex Company Details
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Introduction
11.12.4 Luminex Revenue in Genomics In Cancer Care Business (2018-2023)
11.12.5 Luminex Recent Developments
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Details
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
11.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2018-2023)
11.13.5 Oxford Gene Technology Recent Developments
11.14 PerkinElmer
11.14.1 PerkinElmer Company Details
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Introduction
11.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2018-2023)
11.14.5 PerkinElmer Recent Developments
11.15 Qiagen
11.15.1 Qiagen Company Details
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Introduction
11.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2018-2023)
11.15.5 Qiagen Recent Developments
11.16 GE Healthcare
11.16.1 GE Healthcare Company Details
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Introduction
11.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2018-2023)
11.16.5 GE Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Key Players of Services
Table 5. Global Genomics In Cancer Care Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Genomics In Cancer Care Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Genomics In Cancer Care Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Genomics In Cancer Care Market Share by Region (2018-2023)
Table 9. Global Genomics In Cancer Care Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Genomics In Cancer Care Market Share by Region (2024-2029)
Table 11. Genomics In Cancer Care Market Trends
Table 12. Genomics In Cancer Care Market Drivers
Table 13. Genomics In Cancer Care Market Challenges
Table 14. Genomics In Cancer Care Market Restraints
Table 15. Global Genomics In Cancer Care Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Genomics In Cancer Care Revenue Share by Players (2018-2023)
Table 17. Global Top Genomics In Cancer Care by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2022)
Table 18. Global Genomics In Cancer Care Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Genomics In Cancer Care, Headquarters and Area Served
Table 21. Global Key Players of Genomics In Cancer Care, Product and Application
Table 22. Global Key Players of Genomics In Cancer Care, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Genomics In Cancer Care Revenue Market Share by Type (2018-2023)
Table 26. Global Genomics In Cancer Care Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Genomics In Cancer Care Revenue Market Share by Type (2024-2029)
Table 28. Global Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Genomics In Cancer Care Revenue Share by Application (2018-2023)
Table 30. Global Genomics In Cancer Care Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Genomics In Cancer Care Revenue Share by Application (2024-2029)
Table 32. North America Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Genomics In Cancer Care Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Genomics In Cancer Care Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Genomics In Cancer Care Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Genomics In Cancer Care Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Genomics In Cancer Care Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2024-2029) & (US$ Million)
Table 64. Illumina Company Details
Table 65. Illumina Business Overview
Table 66. Illumina Genomics In Cancer Care Product
Table 67. Illumina Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 68. Illumina Recent Developments
Table 69. Thermo Fisher scientific Company Details
Table 70. Thermo Fisher scientific Business Overview
Table 71. Thermo Fisher scientific Genomics In Cancer Care Product
Table 72. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 73. Thermo Fisher scientific Recent Developments
Table 74. Agilent Company Details
Table 75. Agilent Business Overview
Table 76. Agilent Genomics In Cancer Care Product
Table 77. Agilent Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 78. Agilent Recent Developments
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Genomics In Cancer Care Product
Table 82. Roche Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 83. Roche Recent Developments
Table 84. Cancer Genetics Company Details
Table 85. Cancer Genetics Business Overview
Table 86. Cancer Genetics Genomics In Cancer Care Product
Table 87. Cancer Genetics Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 88. Cancer Genetics Recent Developments
Table 89. Beckman Coulter Company Details
Table 90. Beckman Coulter Business Overview
Table 91. Beckman Coulter Genomics In Cancer Care Product
Table 92. Beckman Coulter Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 93. Beckman Coulter Recent Developments
Table 94. Bio-Rad Company Details
Table 95. Bio-Rad Business Overview
Table 96. Bio-Rad Genomics In Cancer Care Product
Table 97. Bio-Rad Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 98. Bio-Rad Recent Developments
Table 99. Danaher Company Details
Table 100. Danaher Business Overview
Table 101. Danaher Genomics In Cancer Care Product
Table 102. Danaher Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 103. Danaher Recent Developments
Table 104. Sigma Aldrich Company Details
Table 105. Sigma Aldrich Business Overview
Table 106. Sigma Aldrich Genomics In Cancer Care Product
Table 107. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 108. Sigma Aldrich Recent Developments
Table 109. Pacific Biosciences Company Details
Table 110. Pacific Biosciences Business Overview
Table 111. Pacific Biosciences Genomics In Cancer Care Product
Table 112. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 113. Pacific Biosciences Recent Developments
Table 114. Quest Diagnostics Company Details
Table 115. Quest Diagnostics Business Overview
Table 116. Quest Diagnostics Genomics In Cancer Care Product
Table 117. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 118. Quest Diagnostics Recent Developments
Table 119. Luminex Company Details
Table 120. Luminex Business Overview
Table 121. Luminex Genomics In Cancer Care Product
Table 122. Luminex Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 123. Luminex Recent Developments
Table 124. Oxford Gene Technology Company Details
Table 125. Oxford Gene Technology Business Overview
Table 126. Oxford Gene Technology Genomics In Cancer Care Product
Table 127. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 128. Oxford Gene Technology Recent Developments
Table 129. PerkinElmer Company Details
Table 130. PerkinElmer Business Overview
Table 131. PerkinElmer Genomics In Cancer Care Product
Table 132. PerkinElmer Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 133. PerkinElmer Recent Developments
Table 134. Qiagen Company Details
Table 135. Qiagen Business Overview
Table 136. Qiagen Genomics In Cancer Care Product
Table 137. Qiagen Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 138. Qiagen Recent Developments
Table 139. GE Healthcare Company Details
Table 140. GE Healthcare Business Overview
Table 141. GE Healthcare Genomics In Cancer Care Product
Table 142. GE Healthcare Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 143. GE Healthcare Recent Developments
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics In Cancer Care Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Genomics In Cancer Care Market Share by Type: 2022 VS 2029
Figure 3. Instruments Features
Figure 4. Consumables Features
Figure 5. Services Features
Figure 6. Global Genomics In Cancer Care Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Genomics In Cancer Care Market Share by Application: 2022 VS 2029
Figure 8. Diagnostics Case Studies
Figure 9. Personalized Medicine Case Studies
Figure 10. Drug Discovery Case Studies
Figure 11. Development Case Studies
Figure 12. Research Case Studies
Figure 13. Genomics In Cancer Care Report Years Considered
Figure 14. Global Genomics In Cancer Care Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Genomics In Cancer Care Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Genomics In Cancer Care Market Share by Region: 2022 VS 2029
Figure 17. Global Genomics In Cancer Care Market Share by Players in 2022
Figure 18. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2022
Figure 20. North America Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 22. North America Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 23. North America Genomics In Cancer Care Market Share by Country (2018-2029)
Figure 24. United States Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Genomics In Cancer Care Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 28. Europe Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 29. Europe Genomics In Cancer Care Market Share by Country (2018-2029)
Figure 30. Germany Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Genomics In Cancer Care Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 38. China Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 39. Asia Genomics In Cancer Care Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 41. Asia Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 42. Asia Genomics In Cancer Care Market Share by Region (2018-2029)
Figure 43. Japan Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Country (2018-2029)
Figure 53. Brazil Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 60. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 61. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 62. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 63. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 64. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 65. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 66. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 67. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 68. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 69. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 70. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 71. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 72. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 73. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 74. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Agrigenomics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 87
    Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other technology. The global Agrigenomics market was valued at US$ 4849.2 million in 2023 and is anticipated to reach US$ 7524.5 million by 2030, witnessing a CAGR of 6.4% during The forecast period 2024-2030. Thermo Fisher Scientific,......
  • Global Agrigenomics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Agrigenomics market size was valued at US$ 4743.7 million in 2023. With growing demand in downstream market, the Agrigenomics is forecast to a readjusted size of US$ 7439.4 million by 2030 with a CAGR of 6.6% during review period. The research report highlights the growth potential of the global Agrigenomics market. Agrigenomics are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Agrigenomics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Agrigenomics market size was valued at USD 4989.6 million in 2023 and is forecast to a readjusted size of USD 7564.5 million by 2030 with a CAGR of 6.1% during review period. Agrigenomics is product and scientific services in genomics field for agriculture and livestock. Include DNA extraction and purification, DNA/RNA sequencing, Genotyping, Gene expression profiling, Marker-assisted selection, GMO/Trait purity and other t......
  • Global Gene Editing Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 97
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Editing market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Merck - Horizo??n Discovery - Sangamo BioSciences - Integrated DNA Technologies - Lonza - New England Biolabs - ......
  • Global Agrigenomics Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 101
    Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......
  • Global Agrigenomics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Nov-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Agrigenomics market: According to our latest research, the global Agrigenomics market looks promising in the next 5 years. As of 2022, the global Agrigenomics market was estimated at USD 5139.47 million, and it's anticipated to reach USD 7676.54 million in 2028, with a CAGR of 6.92% during the forecast years. Agrigenomics is defined as the study of the genetic makeup of crops and livestock and how genes influence the produce. Application of genomics ......
  • Global Agrigenomics Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Te......
  • Global Genomics in Cancer Care Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Genomics in Cancer Care market: According to our latest research, the global Genomics in Cancer Care market looks promising in the next 5 years. As of 2022, the global Genomics in Cancer Care market was estimated at USD 4369.0 million, and it's anticipated to reach USD 11429.15 million in 2028, with a CAGR of 17.38% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
  • Gene Editing Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 200
    Gene Editing Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene editing deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene editing deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene editing deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs